# Mirador Biomedical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/mirador-biomedical

- Industry: Medical Devices & Equipment
- Headquarters: Seattle, US
- Website: www.miradorbiomedical.com
- Total disclosed funding: $1.5M
- Latest round: Series B (Jan 31, 2011)
- Investors on record: 2

## About

Mirador Biomedical specializes in advanced medical devices aimed at improving vascular access procedures, notably with their Compass™ pressure measurement device, enhancing safety in critical healthcare environments.Mirador Biomedical, founded in 2009 and headquartered in Seattle, US, develops advanced medical devices. The company has undergone significant changes, becoming part of Centurion Medical Products in October 2014. The founder's previous history is not disclosed. To date, Mirador Biomedical has completed two deals, with the most recent one occurring on October 1, 2014, during which they raised USD 1.50 mn in a Series B funding round from investors including Summit Capital and WRF Capital, amounting to a total of USD 1.50 mn raised across funding rounds.Mirador Biomedical, now part of Centurion Medical Products, specializes in advanced medical devices aimed at improving vascular access procedures. Their flagship product, the Compass™ pressure measurement device, is designed to enhance safety during vascular access by preventing inadvertent arterial cannulation, a common complication in procedures such as thoracentesis and lumbar puncture. The Compass device operates by providing real-time pressure readings, which enables healthcare professionals to make informed decisions during these critical procedures. The primary end users of this technology include physicians and medical personnel in hospitals and clinics, particularly in the United States and select international markets. The company focuses on serving hospitals, specialty clinics, and educational institutions, emphasizing the importance of patient safety and procedural efficacy in its product offerings.Revenue for Mirador Biomedical is generated through direct sales of its medical devices, primarily the Compass™ pressure measurement systems, to healthcare institutions. The company engages in a business-to-business (B2B) model, supplying hospitals and clinics that require safe and effective vascular access solutions. Transactions are structured as outright purchases, with institutions integrating the devices into their existing medical practices. Partnerships with medical supply distributors may also facilitate product reach in various geographical markets. Pricing models are tailored to institutional needs, reflecting the specialized nature of the Compass devices, although specific pricing details are not disclosed. Revenue is driven by the increasing demand for enhanced safety measures in medical procedures, positioning the company as a key player in the biomedical field.Following its acquisition by Centurion Medical Products, Mirador Biomedical is expected to leverage resources for future growth. The company aims to expand its product line with new innovations in vascular access technology, although specific upcoming products and release dates have not been detailed. Geographically, Mirador seeks to penetrate additional international markets beyond the US, targeting regions with growing healthcare needs by 2025. The recent funding will support these initiatives, allowing for enhanced research and development efforts to advance their medical device offerings.

## Funding rounds

- Series B, Jan 31, 2011, $1.5M — WRF Capital, Summit Capital

## Investors

- WRF Capital (https://capitalatlas.ai/funds/wrf-capital) — Series B
- Summit Capital — Series B